Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-034987
Filing Date
2024-02-14
Accepted
2024-02-14 06:55:57
Documents
1
Group Members
SCULPTOR CAPITAL HOLDING CORP.SCULPTOR CAPITAL HOLDING II LLCSCULPTOR CAPITAL II LPSCULPTOR CAPITAL MANAGEMENT, INC.SCULPTOR CREDIT OPPORTUNITIES MASTER FUND, LTD.SCULPTOR ENHANCED MASTER FUND, LTD.SCULPTOR MASTER FUND, LTD.SCULPTOR SC II LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d781801dsc13ga.htm SC 13G/A 160832
  Complete submission text file 0001193125-24-034987.txt   162991
Mailing Address 9 WEST 57TH STREET, 39TH FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET, 39TH FLOOR NEW YORK NY 10019 2127900165
Sculptor Capital LP (Filed by) CIK: 0001054587 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
Type: SC 13G/A | Act: 34 | File No.: 005-87833 | Film No.: 24632144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)